Gore begins $857M Bard payback with $36M royalty payment

Thu, 10/31/2013 - 1:58pm
Mass Device

W.L. Gore & Assoc. begins the payback of the more than $857 million it owes stent graft rival C.R. Bard for patent infringement with a $36 million royalty check.

Gore begins $857M Bard payback with $36M royalty payment

W.L. Gore & Associates began paying out the $857.4 million it owes C.R. Bard (NYSE:BCR) for infringing a stent graft patent with a $35.7 million royalty check, according to court documents.

Gore could still be on the hook for another $206.5 million, according to the documents.

Earlier this month a federal judge upheld Bard's win in the decade-long legal war between the medical device companies, ruling that Gore's infringement was willful – a decision that opens the door to the possibility of triple damages for bard.



Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.